Literature DB >> 2921789

Will the increased military low-level flying activity in Labrador be detrimental to the hearing of humans in the region?

J D Baxter1, R West, A Miller.   

Abstract

The Government of Canada has directed the Department of National Defence to encourage our NATO allies to increase use of their facilities at Goose Bay, Labrador. This has already resulted in a substantial increase in the amount of military flying in the area, and more is projected. Much of the flying is done at very low altitude. The aboriginal people in the region (the Innu and, to a lesser extent, the Inuit) are demanding a halt to low-level military flying, and their representatives claim that the noise from the low-flying jet aircraft can cause hearing loss and ear disease. A survey on the ground in the area measured noise levels up to 127.7 dBA with very brief exposure levels. A task force commission to look at the problem concluded that occasionally low-level subsonic overflights might produce noise levels that were potentially damaging to hearing, but that the probability of this happening is at present very low because of the low frequency of flights. This might change if the frequency of flights increases.

Entities:  

Mesh:

Year:  1989        PMID: 2921789

Source DB:  PubMed          Journal:  J Otolaryngol        ISSN: 0381-6605


  3 in total

1.  Effects of noise pollution over the blood serum immunoglobulins and auditory system on the VFM airport workers, Van, Turkey.

Authors:  Zafer Akan; Mehmet Ali Körpinar; Metin Tulgar
Journal:  Environ Monit Assess       Date:  2010-08-21       Impact factor: 2.513

2.  A field study on the immediate effects of exposure to low-altitude flights on heart rate and arrhythmia in patients with cardiac diseases.

Authors:  H Brenner; A Oberacker; W Kranig; R Buchwalsky
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

3.  Jets over Labrador and Quebec: noise effects on human health.

Authors:  J Rosenberg
Journal:  CMAJ       Date:  1991-04-01       Impact factor: 8.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.